Clinical Trials
9 trialsNCT01843868 2024-08-07
Emesis Control Study in Non-Hodgkin Lymphoma Patients Receiving R-CHOP
Australasian Leukaemia and Lymphoma Group
Phase NA Withdrawn
NCT00430313 2023-03-29
Effects of Acupoint Electro-stimulation on Preventing Nausea and Vomiting Induced by Cisplatin or Oxaliplatin
M.D. Anderson Cancer Center
Phase NA Withdrawn
NCT03639415 2021-03-08
Change the Dose Frequency of Controlled-Release Oxycodone to Refractory Pain
Fujian Cancer Hospital
Phase 4 Withdrawn
NCT01980160 2015-10-02
Relief Band as an Adjunct to Antiemetic Therapy in Patients Who Receive Mod to Highly Emetogenic Chemotherapy
Christiana Care Health Services
Phase NA Withdrawn
NCT01687751 2015-05-25
Pilot Study Comparing Treatment With Dexmedetomidine to Midazolam for Symptom Control in Advanced Cancer Patients
Fraser Health
Phase 2 Withdrawn
NCT00891761 2015-04-17
A Study of IV Casopitant for the Prevention of Nausea and Vomiting Caused By Cisplatin-Based Highly Emetogenic Chemotherapy
GlaxoSmithKline
Phase 3 Withdrawn
NCT01017809 2015-03-18
Prolonged Emend in a Study (NYU 03-67) of Oxaliplatin and Topotecan in Previously Treated Ovarian Cancer
NYU Langone Health
Phase NA Withdrawn
NCT00499668 2013-04-02
Aprepitant or Ondansetron in Treating Nausea and Vomiting Caused By Opioids in Patients With Cancer
Vanderbilt-Ingram Cancer Center
Phase NA Withdrawn
NCT00903305 2013-02-01
Nurse-Provided Care or Standard Care in Treating Patients With Stage I, Stage II, or Stage III Breast Cancer
City of Hope Medical Center
Phase NA Withdrawn